Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Progress in Brain Research|September 18, 2025
Expressive resource in a clinical psychedelic study: Art as an integration toolHandersson Barros, Marcelo Falchi-Carvalho, Lucas O Maia, et al.Journal of Psychopharmacology (Oxford, England)|July 9, 2026
Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depressionRaynara Bolcont, Fernanda Palhano-Fontes, Handersson Barros, et al.Journal of Clinical Psychopharmacology|December 20, 2024
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in DepressionVagner Deuel de O Tavares, Kaike Thiê da Costa Gonçalves, Maria Luiza de Morais Barros, et al.European Archives of Psychiatry and Clinical Neuroscience|October 29, 2024
Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practicesKaike Thiê da Costa Gonçalves, Vagner Deuel O de Tavares, Maria Luiza de Morais Barros, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2023
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialMarcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva, et al.Psychedelic Medicine (New Rochelle, N.Y.)|May 8, 2025
The Antidepressant Effects of Vaporized N,N-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant DepressionMarcelo Falchi-Carvalho, Handersson Barros, Raynara Bolcont, et al.Journal of Affective Disorders|December 17, 2025
Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive proteinPatricia Cavalcanti-Ribeiro, Lara Carvalho Araújo Melo De Souza, Vagner Deuel O de Tavares, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 18, 2025
Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trialIsabel Wießner, Marcelo Falchi-Carvalho, Sophie Laborde, et al.Journal of Affective Disorders|September 28, 2024
Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration studyFernanda Palhano-Fontes, Patricia Cavalcanti-Ribeiro, Kaike Thiê da Costa Gonçalves, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2025
Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depressionMarcelo Falchi-Carvalho, Fernanda Palhano-Fontes, Isabel Wießner, et al.Pageof 1